Our first paper proved the mimics are chemically different. This one follows the money and shows why that's no accident — a supply-chain and cost breakdown of the five terpenes that define a real cannabis profile.
Free · ~32-page PDF
We ran three of our hemp cultivars and two leading "cannabis mimic" products through chiral gas chromatography — the test that reads not just which terpenes are present, but which mirror-image form each one takes. The mimics didn't match cannabis. They matched the cheap commodity sources their molecules actually came from.
That paper proved the what. This one answers the obvious next question: why?
Read White Paper 1 →The molecules that make a cannabis profile authentic are either unavailable, priced out of reach, or impossible to source through the supply chains every botanical blender uses. When a formulator buys "limonene," "linalool," or "β-pinene," what shows up is shaped by the industry that made it — citrus juice, lavender fields, paper mills — not by cannabis.
Botanical blending isn't an authenticity strategy. It's a cost strategy. Here's the proof, one compound at a time.
d-limonene is one of the cheapest natural ingredients on earth — a byproduct of the global orange-juice industry, distilled out of peel waste. So it's the default "limonene" in every mimic blend. The problem: cannabis doesn't make d-limonene. It makes l-limonene, the mirror image. Both leading mimics we tested came back 97–99% d-limonene — chemically indistinguishable from orange oil.
Matching cannabis would mean sourcing l-limonene, which has no waste stream, no agricultural feedstock, and no viable synthetic route at scale. The cost runs on the order of 10× — up to 10–50× depending on grade. No blend built to compete on price absorbs that on a major ingredient.
Commodity d-limonene vs. cannabis-correct l-limonene. The authentic form is so far off the commodity scale we don't anchor it to a price — the multiple is the point.
All five compounds, the full chiral dataset, and the supply-chain breakdown — free.
Linalool is in most perfumed products you can name, but nearly all of it is the (−) form from lavender, or a 50/50 synthetic mix. Cannabis makes (+)-linalool — the opposite. The only natural (+) source, coriander, is impure, expensive, and grown as a spice, not an oil crop. Getting it to cannabis purity runs an estimated 10–30× commodity cost.
Almost all commodity β-pinene is pulled from crude sulfate turpentine — a waste stream of the Kraft pulp-and-paper process. It's nearly pure (−)-β-pinene. Cannabis makes the same dominant form but at a very different ratio, carrying far more of the (+) version. The mimics we tested matched turpentine, not cannabis — and the (+)-β-pinene you'd need to correct the ratio isn't sold at any usable scale.
Every other compound here has a commodity supply chain, even if it's the wrong form. Terpinolene doesn't. No waste stream, no industrial byproduct, no scale. It's the defining note of an entire class of sativa-leaning strains — and the one a blender simply can't source at the right level. So they leave it short, and the profile falls apart.
Myrcene is the most abundant terpene in most cannabis — and looks easy to source at a couple dollars a kilo. But almost all of it is synthetic, cracked from paper-mill β-pinene in an industrial reactor. Same formula as the myrcene in cannabis; none of the biology. It's achiral, so the tell isn't the molecule — it's the ratio. And matching that means sourcing everything around it correctly at the same time. That's where the math breaks.
These aren't five separate problems — a blender has to solve all five at once, in one formula, at a price that still sells. Build the same five-terpene blend two ways and the gap is stark: roughly $15/kg with commodity ingredients, about $85/kg with the cannabis-correct ones. A 5–6× jump on the terpene fraction alone — a cost no blending operation absorbs.
And that's the floor. It only counts the five easy compounds — a full profile has dozens more, some you can't buy at all.
Every commodity supply chain leads to the same dead end: the right molecule costs too much, comes in the wrong form, or doesn't exist for sale. That leaves one path that isn't a workaround. Extract the terpene fraction from the plant that made it, and the ratios, the mirror-image forms, and the full set of compounds come with it — not because anyone sourced them, but because the plant already did. If the goal is an authentic cannabis experience, the molecules have to come from cannabis.
The complete analysis — every compound, every supply chain, the full chiral dataset behind it.
Step 1: one click. Fields appear next.
No spam. We'll email the PDF and the occasional research update — unsubscribe anytime.